CAMP FY 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$364M-0.6% YoY

Gross Profit

$148M40.6% margin

Operating Income

$20M5.4% margin

Net Income

$18M5.1% margin

EPS (Diluted)

$0.52

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$37M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$604M

Total Liabilities

$398M

Stockholders' Equity

$206M

Cash & Equivalents

$257M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$364M	$366M	-0.6%
Gross Profit	$148M	$151M	-2.1%
Operating Income	$20M	$8M	+147.6%
Net Income	$18M	$17M	+10.7%